Molecular Diagnostic Laboratory Services

The United States Agency for International Development, located in Washington, DC, is seeking a contractor to provide continuous, fully managed molecular diagnostic goods and services. The agency needs to support three primary program areas, which include HIV viral load and early infant diagnosis testing for treatment monitoring and epidemic control, tuberculosis diagnosis and drug-resistant tuberculosis testing for national control programs, and pre-positioned testing capacity for global health security pathogens. These high-consequence infectious disease threats include Ebola, Marburg, Lassa fever, and other emerging pathogens. The scope of work may also expand to cover additional testing areas such as Human Papilloma Virus, Hepatitis B, Hepatitis C, and other sexually transmitted infections. The agency requires the selected contractor to perform all work onsite. Bidders must be onshore entities located within the United States to be eligible for this opportunity. The agency is currently looking for proposals to determine the budget and financial structure of the agreement. Bidders must submit their responses digitally, either via email or through the designated online portal. The agency has not disclosed specific evaluation criteria or key milestone dates in the initial solicitation details.